VLCC Cycle-Peak Valuation — Session Summary
Date: March 2, 2026
Updated March 2, 2026 — Market caps refreshed: DHT $3.13B, FRO $8.50B
What Was Done
Objective
Perform a rigorous VLCC cycle-peak valuation backtest comparing DHT Holdings (DHT) and Frontline (FRO), using multiple AI models to cross-validate results and reduce model bias.
Methodology
- Translated Chinese analysis prompt into English
- Ran the same structured prompt across 5 AI models in parallel:
- Claude Opus 4.6, Claude Sonnet 4.6, GPT-5.2, GPT-5.1, Gemini 3 Pro Preview
- Run 1 (Neutral): Historical-based framework — 2026–28 cycle positioned between 2008 and 2020
- Run 2 (Enhanced Bullish): Incorporated structural supply thesis — targets must EXCEED 2008 inflation-adjusted peaks
- Compiled cross-model comparative report with consensus ranges
- Updated with latest market caps (DHT $3.13B, FRO $8.50B) — recalculated all upside figures
Key Parameters
- Fleet conversion: VLCC=1.0, Suezmax=0.5, Aframax/LR2=0.3
- DHT: 24 VLCCs → 24.0 VLCC-eq (pure play)
- FRO: 41V + 24S + 18A → 58.4 VLCC-eq (10–12% mix discount)
- Current prices (Mar 2026): DHT $3.13B ($130M/eq), FRO $8.50B ($146M/eq)
- CPI adjustment: 2008→2026 ≈ 1.51×, 2020→2026 ≈ 1.27×
Bullish Supply Thesis (Run 2)
- VLCC orderbook at historic lows — no deliveries until late 2028
- Sinokor locking up large VLCC capacity
- Shadow fleet (~100+ VLCCs) exiting due to sanctions enforcement
- Aging fleet + accelerating scrapping
- Robust Asian refinery demand
Key Results (Updated for Current Prices)
Consensus Targets (Average of 5 Models)
| Scenario | DHT Target | DHT Upside | FRO Target | FRO Upside |
|---|---|---|---|---|
| Conservative | $3.9B | +23% | $8.2B | −4% |
| Base | $5.0B | +58% | $10.4B | +23% |
| Bullish | $6.2B | +99% | $13.2B | +55% |
Critical Shift: FRO Has Consumed Most of Its Upside
- FRO rallied +89% from $4.5B to $8.5B — consumed ~83% of base-case cycle upside
- DHT rallied +49% from $2.1B to $3.13B — consumed ~57% of base-case cycle upside
- DHT now has 2.5× FRO’s remaining upside (+58% vs +23%)
Model Agreement (Updated)
- 5/5 models: DHT has more upside elasticity (unanimous — was 4/5 before)
- 5/5 models: DHT has better risk-adjusted value (unanimous — was 3/5 before)
- FRO’s conservative case is now negative on average (−4%)
Final Verdict
- DHT: Strong Buy — +58% base upside, pure VLCC convexity, clear winner at current prices
- FRO: Fairly Valued — most of the easy money has been made, only attractive in bull case (+55%)
Technical Notes
Gemini 3 Pro Fix
- Failed in Run 1: Could not handle complex multi-tool orchestration (web search + reasoning)
- Fixed in Run 2: Provided all data directly in prompt with “do NOT use tools” instruction
- Lesson: Gemini 3 Pro works well for direct reasoning but struggles with agentic workflows
Model Behavioral Differences
| Model | Aggressiveness | Tool Use | Strengths | |——-|—————|———-|———–| | Opus 4.6 | Moderate-high | Excellent multi-tool | Most thorough analysis, dual-price sensitivity | | Sonnet 4.6 | Moderate | Good | Best structured math transparency | | GPT-5.2 | Aggressive | Good | Boldest targets, supply-shock regime framing | | GPT-5.1 | Moderate | Good | Most balanced bull/bear consideration | | Gemini 3 Pro | Conservative | Poor (needs self-contained prompt) | Clean premium-to-peak framework |
Files in This Folder
01_Full_Report_EN.md— Complete multi-model analysis (English)02_Session_Summary_EN.md— This file: session summary for future reference03_Full_Report_CN.md— Complete multi-model analysis (Chinese)04_Session_Summary_CN.md— Session summary (Chinese)
Updated March 2, 2026. Market caps: DHT $3.13B, FRO $8.50B. Not investment advice.